VandenBerg Amy 4
4 · OBALON THERAPEUTICS INC · Filed May 17, 2018
Insider Transaction Report
Form 4
VandenBerg Amy
Chief Clinical & Reg Officer
Transactions
- Award
Common Stock (Restricted Stock Award)
[F1]2018-05-15+15,000→ 75,000 total
Holdings
- 6,650
Common Stock
Footnotes (1)
- [F1]The Restricted Shares shall vest as to 100% of the Shares underlying the Award on January 2, 2020, subject to the reporting person's provision of service to the Issuer.
Signature
/s/ Nooshin Hussainy as attorney-in-fact for Amy VandenBerg|2018-05-17